164 results
DEFA14A
CERE
Cerevel Therapeutics Holdings Inc
9 Feb 24
Additional proxy soliciting materials
9:00am
-person board of directors (the “Board”), with two such representatives required to be independent and subject to Pfizer’s prior written consent … McKernan, Gabrielle Sulzberger, are the Bain nominees, Marijn Dekkers and Norbert Riedel are the Bain independent nominees and (ii) Deborah Baron
DEFM14A
qnuqqlxr4q08 ubxyp3
18 Jan 24
Proxy related to merger
7:44am
PRER14A
kvdk fqthsu
18 Jan 24
Preliminary revised proxy
7:19am
PREM14A
meklzn5
5 Jan 24
Preliminary proxy related to merger
5:13pm
DEFA14A
uq7 vskxt8b
7 Dec 23
Additional proxy soliciting materials
8:02am
8-K
EX-10.1
fufcg e93
7 Dec 23
AbbVie to Acquire Cerevel Therapeutics in Transformative Transaction to Strengthen Neuroscience Pipeline
8:00am
8-K
EX-2.1
hycqg nqp3jb037wbgry
7 Dec 23
AbbVie to Acquire Cerevel Therapeutics in Transformative Transaction to Strengthen Neuroscience Pipeline
8:00am
8-K
EX-1.1
6nxdb3 j2t8pivpt9o1
12 Oct 23
Cerevel Therapeutics Announces Proposed Public Offering of Common Stock
4:19pm
424B5
puoux7kn5zf2
12 Oct 23
Prospectus supplement for primary offering
4:16pm
8-K
07jie64k si1ih7pn0
11 Oct 23
Results of Operations and Financial Condition
4:14pm
424B5
nx2yypcpxg4jk
11 Oct 23
Prospectus supplement for primary offering
4:08pm
8-K
fai9c
8 Jun 23
Submission of Matters to a Vote of Security Holders
4:29pm